Levels of neurotransmitter amino acids in the cerebrospinal fluid of patients with acute ischemic insult. 2000

V I Skvortsova, and K S Raevskii, and A V Kovalenko, and V S Kudrin, and L A Malikova, and M A Sokolov, and A A Alekseev, and E I Gusev
Russian State Medical University, Science Research Institute of Pharmacology, Russian Academy of Medical Sciences, Moscow.

The dynamics of excitatory (glutamate, aspartate) and inhibitory (GABA, glycine) neurotransmitter amino acid contents in the cerebrospinal fluid were studied in 110 patients with hemispheric ischemic insult. These studies revealed significant increases in the levels of glutamate and aspartate in the first six hours of illness, and the level and duration of these changes correlated with the severity of the insult. Peak GABA and glycine levels were seen at the end of the first day after strokes, reflecting the delayed activation of the mechanisms of protective inhibition. The insufficiency of GABAergic mediation in strokes located in the hemispheres to a significant extent mirrored the severity of clinical features and the potential of restorative processes. Early significant biochemical criteria were identified for objective assessment of the severity of brain ischemia, and these had prognostic value for the course and outcome of strokes. The most unfavorable prognostic signs were the presence of low (or undetectable) GABA levels in the first days after insult and progressive increases in aspartate levels to the third day on the background of sharp reductions in glutamate levels (after initial elevation on the first day).

UI MeSH Term Description Entries
D007839 Functional Laterality Behavioral manifestations of cerebral dominance in which there is preferential use and superior functioning of either the left or the right side, as in the preferred use of the right hand or right foot. Ambidexterity,Behavioral Laterality,Handedness,Laterality of Motor Control,Mirror Writing,Laterality, Behavioral,Laterality, Functional,Mirror Writings,Motor Control Laterality,Writing, Mirror,Writings, Mirror
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D005680 gamma-Aminobutyric Acid The most common inhibitory neurotransmitter in the central nervous system. 4-Aminobutyric Acid,GABA,4-Aminobutanoic Acid,Aminalon,Aminalone,Gammalon,Lithium GABA,gamma-Aminobutyric Acid, Calcium Salt (2:1),gamma-Aminobutyric Acid, Hydrochloride,gamma-Aminobutyric Acid, Monolithium Salt,gamma-Aminobutyric Acid, Monosodium Salt,gamma-Aminobutyric Acid, Zinc Salt (2:1),4 Aminobutanoic Acid,4 Aminobutyric Acid,Acid, Hydrochloride gamma-Aminobutyric,GABA, Lithium,Hydrochloride gamma-Aminobutyric Acid,gamma Aminobutyric Acid,gamma Aminobutyric Acid, Hydrochloride,gamma Aminobutyric Acid, Monolithium Salt,gamma Aminobutyric Acid, Monosodium Salt
D005998 Glycine A non-essential amino acid. It is found primarily in gelatin and silk fibroin and used therapeutically as a nutrient. It is also a fast inhibitory neurotransmitter. Aminoacetic Acid,Glycine, Monopotassium Salt,Glycine Carbonate (1:1), Monosodium Salt,Glycine Carbonate (2:1), Monolithium Salt,Glycine Carbonate (2:1), Monopotassium Salt,Glycine Carbonate (2:1), Monosodium Salt,Glycine Hydrochloride,Glycine Hydrochloride (2:1),Glycine Phosphate,Glycine Phosphate (1:1),Glycine Sulfate (3:1),Glycine, Calcium Salt,Glycine, Calcium Salt (2:1),Glycine, Cobalt Salt,Glycine, Copper Salt,Glycine, Monoammonium Salt,Glycine, Monosodium Salt,Glycine, Sodium Hydrogen Carbonate,Acid, Aminoacetic,Calcium Salt Glycine,Cobalt Salt Glycine,Copper Salt Glycine,Hydrochloride, Glycine,Monoammonium Salt Glycine,Monopotassium Salt Glycine,Monosodium Salt Glycine,Phosphate, Glycine,Salt Glycine, Monoammonium,Salt Glycine, Monopotassium,Salt Glycine, Monosodium
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001224 Aspartic Acid One of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter. (+-)-Aspartic Acid,(R,S)-Aspartic Acid,Ammonium Aspartate,Aspartate,Aspartate Magnesium Hydrochloride,Aspartic Acid, Ammonium Salt,Aspartic Acid, Calcium Salt,Aspartic Acid, Dipotassium Salt,Aspartic Acid, Disodium Salt,Aspartic Acid, Hydrobromide,Aspartic Acid, Hydrochloride,Aspartic Acid, Magnesium (1:1) Salt, Hydrochloride, Trihydrate,Aspartic Acid, Magnesium (2:1) Salt,Aspartic Acid, Magnesium-Potassium (2:1:2) Salt,Aspartic Acid, Monopotassium Salt,Aspartic Acid, Monosodium Salt,Aspartic Acid, Potassium Salt,Aspartic Acid, Sodium Salt,Calcium Aspartate,Dipotassium Aspartate,Disodium Aspartate,L-Aspartate,L-Aspartic Acid,Magnesiocard,Magnesium Aspartate,Mg-5-Longoral,Monopotassium Aspartate,Monosodium Aspartate,Potassium Aspartate,Sodium Aspartate,Aspartate, Ammonium,Aspartate, Calcium,Aspartate, Dipotassium,Aspartate, Disodium,Aspartate, Magnesium,Aspartate, Monopotassium,Aspartate, Monosodium,Aspartate, Potassium,Aspartate, Sodium,L Aspartate,L Aspartic Acid
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

V I Skvortsova, and K S Raevskii, and A V Kovalenko, and V S Kudrin, and L A Malikova, and M A Sokolov, and A A Alekseev, and E I Gusev
January 1999, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova,
V I Skvortsova, and K S Raevskii, and A V Kovalenko, and V S Kudrin, and L A Malikova, and M A Sokolov, and A A Alekseev, and E I Gusev
January 1998, Journal of neural transmission (Vienna, Austria : 1996),
V I Skvortsova, and K S Raevskii, and A V Kovalenko, and V S Kudrin, and L A Malikova, and M A Sokolov, and A A Alekseev, and E I Gusev
January 1998, Journal of neural transmission (Vienna, Austria : 1996),
V I Skvortsova, and K S Raevskii, and A V Kovalenko, and V S Kudrin, and L A Malikova, and M A Sokolov, and A A Alekseev, and E I Gusev
September 1996, Journal of the neurological sciences,
V I Skvortsova, and K S Raevskii, and A V Kovalenko, and V S Kudrin, and L A Malikova, and M A Sokolov, and A A Alekseev, and E I Gusev
July 2010, Neurochemistry international,
V I Skvortsova, and K S Raevskii, and A V Kovalenko, and V S Kudrin, and L A Malikova, and M A Sokolov, and A A Alekseev, and E I Gusev
May 1991, Casopis lekaru ceskych,
V I Skvortsova, and K S Raevskii, and A V Kovalenko, and V S Kudrin, and L A Malikova, and M A Sokolov, and A A Alekseev, and E I Gusev
August 2001, Clinical chemistry,
V I Skvortsova, and K S Raevskii, and A V Kovalenko, and V S Kudrin, and L A Malikova, and M A Sokolov, and A A Alekseev, and E I Gusev
January 1993, Epilepsia,
V I Skvortsova, and K S Raevskii, and A V Kovalenko, and V S Kudrin, and L A Malikova, and M A Sokolov, and A A Alekseev, and E I Gusev
September 1999, Clinical neurology and neurosurgery,
V I Skvortsova, and K S Raevskii, and A V Kovalenko, and V S Kudrin, and L A Malikova, and M A Sokolov, and A A Alekseev, and E I Gusev
April 2005, Journal of neural transmission (Vienna, Austria : 1996),
Copied contents to your clipboard!